Law ❯ Securities Law ❯ False Statements

Investor Protection

Legal Proceedings Legal Recourse Litigation Outcomes Legal Claims

Law Firms Urge Jasper Therapeutics Investors to Seek Lead‑Plaintiff Role Before Nov. 18 Deadline

The lawsuit alleges undisclosed weaknesses in third‑party manufacturing controls that put briquilimab trial readouts at risk of being confounded.

RxSight Securities Suit Nears Lead-Plaintiff Deadline After 38% Stock Plunge

Rosen Law Firm Alerts iRobot Investors to Sept. 5 Lead-Plaintiff Deadline in Securities Case